Daniel Forton

Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease

Daniel Forton, Howard C. Thomas, Christine Murphy et al. · Hepatology · 2002 · 446 citations · Full text

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 438 citations

Fibrosis, Hepatology, Liver Physiology +9

Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study

Rachael A Evans, Olivia C. Leavy, Matthew Richardson et al. · The Lancet Respiratory Medicine · 2022 · 407 citations · Full text

Efficacy of Sofosbuvir Plus Ribavirin With or Without Peginterferon-Alfa in Patients With Hepatitis C Virus Genotype 3 Infection and Treatment-Experienced Patients With Cirrhosis and Hepatitis C Virus Genotype 2 Infection

Graham R. Foster, Stephen Pianko, Ashley Brown et al. · Gastroenterology · 2015 · 249 citations · Full text

Hepatology, Hepatitis C, Viral Hepatitis +8

Identification of Unique Hepatitis C Virus Quasispecies in the Central Nervous System and Comparative Analysis of Internal Translational Efficiency of Brain, Liver, and Serum Variants

Daniel Forton, Peter Karayiannis, Nadiya Mahmud et al. · Journal of Virology · 2004 · 242 citations · Full text

Viral Replication, Engineering, Immunology +21